Extracting scalar measures from functional data with applications to placebo response.

Average tangent slope Longitudinal data Ordering curves Placebo effects

Journal

Statistics and its interface
ISSN: 1938-7989
Titre abrégé: Stat Interface
Pays: United States
ID NLM: 101471232

Informations de publication

Date de publication:
2021
Historique:
entrez: 28 7 2021
pubmed: 29 7 2021
medline: 29 7 2021
Statut: ppublish

Résumé

In controlled and observational studies, outcome measures are often observed longitudinally. Such data are difficult to compare among units directly because there is no natural ordering of curves. This is relevant not only in clinical trials, where typically the goal is to evaluate the relative efficacy of treatments on average, but also in the growing and increasingly important area of personalized medicine, where treatment decisions are optimized with respect to a relevant patient outcome. In personalized medicine, there are no methods for optimizing treatment decision rules using longitudinal outcomes, e.g., symptom trajectories, because of the lack of a natural ordering of curves. A typical practice is to summarize the longitudinal response by a scalar outcome that can then be compared across patients, treatments, etc. We describe some of the summaries that are in common use, especially in clinical trials. We consider a general summary measure (weighted average tangent slope) with weights that can be chosen to optimize specific inference depending on the application. We illustrate the methodology on a study of depression treatment, in which it is difficult to separate placebo effects from the specific effects of the antidepressant. We argue that this approach provides a better summary for estimating the benefits of an active treatment than traditional non-weighted averages.

Identifiants

pubmed: 34316322
doi: 10.4310/20-sii633
pmc: PMC8313021
mid: NIHMS1649006
doi:

Types de publication

Journal Article

Langues

eng

Pagination

255-265

Subventions

Organisme : NIMH NIH HHS
ID : K01 MH113850
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH068401
Pays : United States

Références

Am J Psychiatry. 1991 Feb;148(2):193-6
pubmed: 1987817
J Clin Psychopharmacol. 2002 Aug;22(4):414-8
pubmed: 12172342
J Comput Graph Stat. 2015 Apr 1;24(2):477-501
pubmed: 26347592
Biometrics. 2014 Sep;70(3):516-25
pubmed: 26228660
Stat Med. 2018 May 20;:
pubmed: 29781174
Adm Policy Ment Health. 2011 Nov;38(6):486-94
pubmed: 21301952
Soc Sci Med. 2009 Jun;68(12):2190-8
pubmed: 19403217
Arch Gen Psychiatry. 1998 Apr;55(4):334-43
pubmed: 9554429
JAMA Psychiatry. 2015 Oct;72(10):1021-8
pubmed: 26288246
Pain. 2015 Apr;156(4):626-634
pubmed: 25775441
J Comput Graph Stat. 2011 Dec 1;20(4):830-851
pubmed: 22368438
Ann Stat. 2011 Apr 1;39(2):1180-1210
pubmed: 21666835
Arch Gen Psychiatry. 1987 Mar;44(3):259-64
pubmed: 3548638
J R Stat Soc Ser C Appl Stat. 2012 May;61(3):453-469
pubmed: 22679339
Int Stat Rev. 2017 Aug;85(2):228-249
pubmed: 28919663

Auteurs

Thaddeus Tarpey (T)

Department of Population Health, New York University, 180 Madison Ave, 5nd Floor, Room 4-53, New York, NY, 10016, USA.

Eva Petkova (E)

Department of Population Health, New York University, 180 Madison Ave, 2th Floor, Room 2-55, New York, NY, 10016, USA.

Adam Ciarleglio (A)

Department of Biostatistics and Bioinformatics, Milken Institute School of Public Health, George Washington University, 950 New Hampshire Avenue, Room 517, Washington, DC, 20052, USA.

Robert Todd Ogden (RT)

Department of Biostatistics, Columbia University, 722 W. 168th Street, 6th Floor, New York, NY 10032, USA.

Classifications MeSH